LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

Home・Elenco Azioni・Crescent Biopharma Inc

C
Crescent Biopharma Inc

Chiusa

SettoreSettore sanitario

13.04 0.77

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

12.53

Massimo

13.17

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+93.93% upside

Notizie sul Sentiment di mercato

By Acuity

100%

361 / 374 Classifica in Healthcare

Crescent Biopharma Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

17 nov 2025, 18:59 UTC

I principali Market Mover

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

17 nov 2025, 23:40 UTC

Discorsi di Mercato

Gold Consolidates Amid Mixed Signals -- Market Talk

17 nov 2025, 23:34 UTC

Discorsi di Mercato

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

17 nov 2025, 22:58 UTC

Discorsi di Mercato

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

17 nov 2025, 22:46 UTC

Discorsi di Mercato

Risk Assets Set to Have a Strong 2026 -- Market Talk

17 nov 2025, 22:06 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

17 nov 2025, 22:02 UTC

Utili

Trip.com Group 3Q Rev $2.6B >TCOM

17 nov 2025, 22:02 UTC

Utili

Trip.com Group 3Q Adj EPS $3.87 >TCOM

17 nov 2025, 22:02 UTC

Utili

Trip.com Group 3Q EPS $4.02 >TCOM

17 nov 2025, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

17 nov 2025, 21:40 UTC

Utili

James Hardie Industries 2Q Adj EPS 26c >JHX

17 nov 2025, 21:40 UTC

Utili

James Hardie Industries 2Q Loss/Shr 10c >JHX

17 nov 2025, 21:39 UTC

Utili

James Hardie Industries 2Q Sales $1.29B >JHX

17 nov 2025, 21:38 UTC

Utili

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 nov 2025, 21:38 UTC

Utili

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

17 nov 2025, 21:10 UTC

Utili

XP Inc. 3Q EPS BRL2.47 >XP

17 nov 2025, 21:10 UTC

Utili

XP Inc. 3Q Rev BRL4.67B >XP

17 nov 2025, 20:20 UTC

Discorsi di Mercato

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

17 nov 2025, 20:12 UTC

Discorsi di Mercato

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

17 nov 2025, 20:12 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

17 nov 2025, 20:09 UTC

Discorsi di Mercato

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

17 nov 2025, 19:29 UTC

Discorsi di Mercato

Gold Slide Continues to Start Week -- Market Talk

17 nov 2025, 19:16 UTC

Utili

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 nov 2025, 18:20 UTC

Acquisizioni, Fusioni, Takeovers

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

17 nov 2025, 16:45 UTC

Acquisizioni, Fusioni, Takeovers

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

17 nov 2025, 16:16 UTC

Utili

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 nov 2025, 16:15 UTC

Utili

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

17 nov 2025, 15:40 UTC

Acquisizioni, Fusioni, Takeovers

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

17 nov 2025, 15:22 UTC

Acquisizioni, Fusioni, Takeovers

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

17 nov 2025, 15:19 UTC

Discorsi di Mercato

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Confronto tra pari

Modifica del prezzo

Crescent Biopharma Inc Previsione

Obiettivo di Prezzo

By TipRanks

93.93% in crescita

Previsioni per 12 mesi

Media 25.25 USD 93.93%

Alto 28 USD

Basso 22 USD

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Crescent Biopharma Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

5 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 5 che hanno fornito valutazioni azionarie a Crescent Biopharma Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

361 / 374 Classifica in Settore sanitario

Notizie finanziarie

Altri titoli del settore

LLY

Eli Lilly and Co.

1,021.76

↓-0.21%

JNJ

Johnson and Johnson

199.29

↑ +1.67%

ABBV

AbbVie Inc

233.81

↑ +0.62%

UNH

UnitedHealth Group Inc

320.41

↓-0.3%

AZN

AstraZeneca PLC ADR

89.34

↑ +0.22%

C Crescent Biopharma Inc

Panoramica

Variazione del prezzo dell'azione

Raccomandazioni

Notizie sul Sentiment di mercato

Crescent Biopharma Inc Grafico

Notizie correlate

Confronto tra pari

Crescent Biopharma Inc Previsione

Obiettivo di Prezzo

Consenso sulla valutazione

Sentiment

Notizie finanziarie

Altri titoli del settore

C
Crescent Biopharma Inc